A potential biomarker based on clinical-radiomics nomogram for predicting survival and adjuvant chemotherapy benefit in resected node-negative, early-stage lung adenocarcinoma

BACKGROUND: We aimed to construct a clinical-radiomics nomogram to predict disease-free survival (DFS) and the added survival benefit of adjuvant chemotherapy (ACT) for node-negative, early-stage (I–II) lung adenocarcinoma (ADC). METHODS: In this retrospective study including 310 patients from two i...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Xiaoling, Lv, Wenzhi, Wang, Cong, Tu, Dehao, Qiao, Jinhan, Fan, Chanyuan, Niu, Jiandong, Zhou, Wen, Liu, Qiuyu, Xia, Liming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8828517/
https://www.ncbi.nlm.nih.gov/pubmed/35242363
http://dx.doi.org/10.21037/jtd-21-1520

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8828517/
https://www.ncbi.nlm.nih.gov/pubmed/35242363
http://dx.doi.org/10.21037/jtd-21-1520

Ejemplares similares